TAMPA, Fla. and LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today ...
RAS-2023 Final Result: The Rajasthan Public Service Commission (RPSC) has released the results of the RAS-2023 exam. According to the commission, a total of 972 candidates have passed the exam, ...
Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...
Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...
As AI workloads scale and data center operations become increasingly complex, it is critical to keep the infrastructure up and running. Total Cost of Ownership (TCO) is a key metric that includes not ...
Have you ever been overwhelmed by messy spreadsheets or struggled to collect data in an organized way? Imagine a scenario where instead of juggling multiple tabs and rows, you could guide users ...
– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg ...
Where do maps and Ordnance Survey data take us? Well, it could be further than just for directions to the local supermarket… Newcastle release damning 37-word Alexander Isak statement after Liverpool ...
The Trump administration is collecting data on all Americans, and they are enlisting the data analysis company Palantir to do it. The New York Times reports that President Trump has enlisted the firm, ...
A company’s content lies largely in “unstructured data”—those emails, contracts, forms, Sharepoint files, recordings of meetings and so forth created via work processes. That proprietary content makes ...
Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback